Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

The drug shortages are the result of manufacturing problems, increased demand, and other issues.View on euronews ...

Meanwhile, an article in the Financial Times (FT) notes that four drugs discarded by GSK have now reached a combined value of $5 billion, which, the paper says, raises questions about the decision ...

they can seek approval for a truncated list of uses – the skinny label – that only includes those that are off-patent. The case focuses on GSK's heart drug Coreg (carvedilol), which was ...

A report by drugs firm GSK - seen by the BBC - shows it learned ... of really quite dramatic changes that can occur," he says. A list of organisations in the UK offering support and information ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that ...

Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced its eighth annual Female Founders list, honoring HealthTree CEO and Founder ...

By Derin Otuyelu Late on Thursday last week, reports emerged that the Federal Competition and Consumer Protection Commission ...